This measure "supposes a real paradigm shift" in the treatment of the disease
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Association of COPD Patients (APEPOC) has expressed its satisfaction at the approval of the public funding of the first biological treatment against chronic obstructive pulmonary disease in Spain, which it has described as a "historical news".